Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines

Leukemia Research

Volumn 34, Issue 6, 2010, Pages 757-762

  Marques, Daiane S ^a   Sandrini, Juliana Z ^a   Boyle, Robert T ^a   Marins, Luis F ^a   Trindade, Gilma S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

Author keywords

ABCB1; ABCC1; ABCG2; CD34; CD38; CML; Oct 4

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CD34 ANTIGEN; CD38 ANTIGEN; MULTIDRUG RESISTANCE PROTEIN 1; OCTAMER TRANSCRIPTION FACTOR 4;

ARTICLE; BINDING SITE; CANCER STEM CELL; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROMOTER REGION;

ANTIGENS, CD34; ANTIGENS, CD38; ANTIGENS, SURFACE; ATP-BINDING CASSETTE TRANSPORTERS; BINDING SITES; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; K562 CELLS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MEMBRANE GLYCOPROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; P-GLYCOPROTEIN; PROMOTER REGIONS, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 77952089570     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.11.004     Document Type: Article

References (43)

1. Stavrovskaya A.A., Stromskaya T.P. Transport proteins of the ABC family and multidrug resistance of tumor cells. Biochemistry 2008, 73:592-604.
2. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993, 62:385-427.
3. Higgins C.F. Multiple molecular mechanisms for multidrug resistance transporters. Nature 2007, 446:749-757.
4. Szakacs G., Paterson J.K., Ludwig J.A., Booth_Genthe C., Gottesman M.M. Targeting multidrug resistance in câncer. Nat Rev Drug Discov 2006, 5:219-234.
5. Neyfakh A.A. Use of fluorescent dyes as molecular probes for the study of the multidrug resistance. Exp Cell Res 1988, 174:168-176.
6. Dean M., Rzhetsky A., Allikmets R. The human ATP - binding cassete (ABC) superfamily. Genome Res 2001, 11:1156-1166.
7. Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005, 5:275-284.
8. Tan B.T., Park C.Y., Ailles L.E., Weissman I.L. The cancer stem cell hypothesis: a work in progress. Lab Invest 2006, 86:1203-1207.
9. Wicha M.S., Liu S., Dontu G. Cancer Stem Cells: an old idea-a paradigm shift. Cancer Res 2006, 66:1883-1890.
10. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
11. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-737.
12. Raaijmakers M.H. ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia. Leukemia 2007, 21:2094-2102.
13. Zhou S., Morris J.J., Barnes Y., Lan L., Schuetz J.D., Sorrentino B.P. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc Natl Acad Sci USA 2002, 99:12339-12344.
14. Costello R.T., Mallet F., Gaugler B., Sainty D., Arnoulet C., Gastaut J.A., et al. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decrease sensitivity to chemoteraphy and Fas-indiced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res 2000, 60(16):4403-4411.
15. Berardi A., Wang A., Levine J., Lopez P., Scadden D. Functional isolation and characterizations of human hematopoietic stem cells. Science 1995, 267:104-108.
16. Chaudhary P.M., Roninson I.B. Expression and activity of P glycoprotein, a multidrug efflux pump in human hematopoietic stem cells. Cell 1991, 66:85-94.
17. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001, 7:1028-1034.
18. De Grouw E.P., Raaijmakers M.H., Boezeman J.B., van der Reijden B.A., van de Locht L.T., de Witte T.J., et al. Preferential expression of a high number of ATP binding cassette transporters in both normal and leukemic CD34+CD38- cells. Leukemia 2006, 20:750-754.
19. Good J.R., Kuspa A. Evidence that a cell-type-specific efflux pump regulates cell differentiation in dictyostelium. Dev Biol 2000, 220:53-61.
20. Okamoto K., Okazawa H., Okuda A., Sakai M., Muramatsu M., Hamada H. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 1990, 60:461-472.
21. Schöler H.R., Ruppert S., Suzuki N., Chowdhury K., Gruss P. New type of POU domain in germ line-specific protein Oct-4. Nature 1990, 344:435-439.
22. Rosner M.H., Vigano M.A., Ozato K., Timmons P.M., Poirier F., Riqby P.W., et al. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 1990, 345:686-692.
23. Chen Y.-C., Hsu H.-S., Chen Y.-W., Tsai T.-H., How C.-K., Wang C.-Y., et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD-133 positive cells. PLoS ONE 2008, 3(7):e2637.
24. Boiani M., Scholer H.R. Regulatory networks in embryo-derived pluripotent stem cells. Nat Ver Mol Cell Biol 2005, 6:872-884.
25. Lamb K.A., Rizzino A. Effects of differentiation on the transcriptional regulation of the FGF-4 gene: critical roles played by a distal enhancer. Mol Reprod Dev 1998, 51:218-224.
26. Kraft H.J., Mosselman S., Smits H.A., Hohenstein P., Piek E., Chen Q., et al. Oct-4 regulates alternative platelet-derived growth factor alpha receptor gene promoter in human embryonal carcinoma cells. J Biol Chem 1996, 271:12873-12878.
27. Tai M.H., Chang C.C., Olson L.K., Tosko J.E. Oct-4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005, 26:495-502.
28. Tantin D., Gemberling M., Callister C., Fairbrother W.G. High-throughput biochemical analysis of in vivo location data reveals novel distinct classes of POU5F1(Oct4)/DNA complexes. Genome Res 2008, 18(4):631-639.
29. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and matInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995, 23:4878-4884.
30. Fielding R.T. Architectural styles and the design of network-based software architectures 2000, University of California, Irvine.
31. Kubonishi I., Takeuchi S., Uemura Y., Kamioka M., Asahi Y., Ohtsuki Y., et al. Direct transplantation of chronic myelogenous leukemia cells into nude mice and establishment of a leukemic stem cell (Ph1+, CD34+) line dependent on mouse boné marrow stromal cells in vitro. Jpn J Cancer Res 1995, 86(5):451-459.
32. Huang S., Terstappen L. Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38- hematopoietic stem cells. Blood 1994, 83:1515-1526.
33. Petzer A.L., Hogge D.E., Landsdorp P.M., Reid D.S., Eaves C.J. Self-Renewal of primitive human hematopoietic cells (long-term-culture- Initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 1996, 93:1470-1474.
34. Rumjanek V.M., Trindade G.S., Wagner-Souza K., Meletti-de-Oliveira M.C., Marques-Santos L.F., Maia R.C., et al. Multidrug resistance in tumour cells: characterisation of the multidrug resistant cell line K562-Lucena 1. Acad Br Ciências 2001, 73(1):57-69.
35. Trindade G.S., Farias S.L.A., Rumjanek V.M., Capella M.A.M. Methylene blue reverts multidrug resistance: sensitivity of multidrug resistant cells to this dye and its photodynamic action. Cancer Lett 1999, 151:161-167.
36. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Rishi A.K., et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 1998, 95:15665-21567.
37. Scharenberg C.W., Harkey M.A., Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 effluxpump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002, 99:507-512.
38. Kim M., Turnquist H., Jackson J., Sqaqias M., Yan Y., Gonq M., et al. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 2002, 8:22-28.
39. Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002, 2:48-58.
40. Farnham P.J. Insights from genomic profiling of transcription factors. Nature 2009, 10:605-616.
41. Chen X., Xu H., Yuan P., Fang F., Huss M., Vega V.B., et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133:1106-1117.
42. Chew J.-L., Loh Y.-H., Zhang W., Chen X., Tam W.L., Yeap L.S., et al. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol 2005, 6031-6046.
43. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H., Jones D.L., et al. Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 2006, 66:9339-9344.